Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05742360 · ClinicalTrials.gov registry record

Effect of CPAP on Blood Pressure in Excessively Sleepy Obstructive Sleep Apnea Subtype

A clinical trial of Obstructive Sleep Apnea, sponsored by Ohio State University.

Recruiting
Registry status
227
Enrollment target
2
Study locations

NCT05742360 is a study of Obstructive Sleep Apnea that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 227 participants, roughly in line with the 220-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target. The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05742360, a study of Obstructive Sleep Apnea, is actively recruiting participants, sponsored by Ohio State University.

RECRUITING
Registry status
227 participants
Enrollment target
2
Study locations

Study Summary

The primary objective of this study is to determine the longer-term (6 months) effect of CPAP therapy on change in 24-hour mean blood pressure (24hMBP) in OSA subjects with the excessively sleepy symptom subtype.

Conditions Studied

Interventions

  • DEVICE CPAP therapy

Study Locations (2)

Ohio

  • The Ohio State University - Martha Morehouse Medical Pavilion, Suite 2600 - Columbus

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 227 participants
Start Date 2023-02-07
Est. Completion 2028-03-01

Sponsor

Ohio State University

552 total trials

What the Registry Record Tells You About NCT05742360

The ClinicalTrials.gov registry entry for NCT05742360 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 227 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 220-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which CPAP therapy is the first listed.

NCT05742360 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Ohio, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05742360 about?

NCT05742360 is a clinical study titled "Effect of CPAP on Blood Pressure in Excessively Sleepy Obstructive Sleep Apnea Subtype". The primary objective of this study is to determine the longer-term (6 months) effect of CPAP therapy on change in 24-hour mean blood pressure (24hMBP) in OSA subjects with the excessively sleepy symptom subtype.

What is the current status of trial NCT05742360?

This trial is currently recruiting. The enrollment target is 227 participants. The study started on 2023-02-07. Estimated completion is 2028-03-01.

What conditions does trial NCT05742360 study?

This clinical trial studies the following conditions: Obstructive Sleep Apnea.

What interventions are being tested in trial NCT05742360?

The interventions under investigation include: CPAP therapy (DEVICE).

Who is sponsoring clinical trial NCT05742360?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05742360 being conducted?

This trial has 2 study locations across Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obstructive Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.